Matches in Nanopublications for { ?s ?p "[We report a case of secondary acute myelogenous leukemia (AML) with 11q23 cytogenetic abnormality and mixed lymphoid leukemia (MLL) gene expression in a patient treated with Y90 labeled anti-CD20 antibody (Zevalin).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- assertion description "[We report a case of secondary acute myelogenous leukemia (AML) with 11q23 cytogenetic abnormality and mixed lymphoid leukemia (MLL) gene expression in a patient treated with Y90 labeled anti-CD20 antibody (Zevalin).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We report a case of secondary acute myelogenous leukemia (AML) with 11q23 cytogenetic abnormality and mixed lymphoid leukemia (MLL) gene expression in a patient treated with Y90 labeled anti-CD20 antibody (Zevalin).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We report a case of secondary acute myelogenous leukemia (AML) with 11q23 cytogenetic abnormality and mixed lymphoid leukemia (MLL) gene expression in a patient treated with Y90 labeled anti-CD20 antibody (Zevalin).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We report a case of secondary acute myelogenous leukemia (AML) with 11q23 cytogenetic abnormality and mixed lymphoid leukemia (MLL) gene expression in a patient treated with Y90 labeled anti-CD20 antibody (Zevalin).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We report a case of secondary acute myelogenous leukemia (AML) with 11q23 cytogenetic abnormality and mixed lymphoid leukemia (MLL) gene expression in a patient treated with Y90 labeled anti-CD20 antibody (Zevalin).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP380967.RAQSr6e03v5yhGFDLq2XumYDe3JWw5z_e1jITbAYojeLI130_assertion description "[We report a case of secondary acute myelogenous leukemia (AML) with 11q23 cytogenetic abnormality and mixed lymphoid leukemia (MLL) gene expression in a patient treated with Y90 labeled anti-CD20 antibody (Zevalin).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP380967.RAQSr6e03v5yhGFDLq2XumYDe3JWw5z_e1jITbAYojeLI130_provenance.
- NP380968.RAiJNkypTl07gzMN6kiVCv94lxY8lhQLh8jaZ5O6gCcs0130_assertion description "[We report a case of secondary acute myelogenous leukemia (AML) with 11q23 cytogenetic abnormality and mixed lymphoid leukemia (MLL) gene expression in a patient treated with Y90 labeled anti-CD20 antibody (Zevalin).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP380968.RAiJNkypTl07gzMN6kiVCv94lxY8lhQLh8jaZ5O6gCcs0130_provenance.
- NP290947.RANqWfMn_iUBeI5zrd0LlDw7v3PKEve6oRiMIwpA3srMc130_assertion description "[We report a case of secondary acute myelogenous leukemia (AML) with 11q23 cytogenetic abnormality and mixed lymphoid leukemia (MLL) gene expression in a patient treated with Y90 labeled anti-CD20 antibody (Zevalin).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP290947.RANqWfMn_iUBeI5zrd0LlDw7v3PKEve6oRiMIwpA3srMc130_provenance.
- NP911161.RA0wizb8sI-95QvgNbJy2OZmZYK9KNjJf568G0IBwT7uk130_assertion description "[We report a case of secondary acute myelogenous leukemia (AML) with 11q23 cytogenetic abnormality and mixed lymphoid leukemia (MLL) gene expression in a patient treated with Y90 labeled anti-CD20 antibody (Zevalin).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP911161.RA0wizb8sI-95QvgNbJy2OZmZYK9KNjJf568G0IBwT7uk130_provenance.
- NP380966.RA5bQsmo8_ide4bLiBH9iFvQjIlaTduPZmh46sKLDAzYA130_assertion description "[We report a case of secondary acute myelogenous leukemia (AML) with 11q23 cytogenetic abnormality and mixed lymphoid leukemia (MLL) gene expression in a patient treated with Y90 labeled anti-CD20 antibody (Zevalin).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP380966.RA5bQsmo8_ide4bLiBH9iFvQjIlaTduPZmh46sKLDAzYA130_provenance.